bpV(pic)
| Code | Size | Price |
|---|
| AG-CR1-0043-M005 | 5 mg | £60.00 |
Quantity:
| AG-CR1-0043-M025 | 25 mg | £210.00 |
Quantity:
Prices exclude any Taxes / VAT
Overview
Regulatory Status: RUO
Shipping:
-20°C
Storage:
-20°C
Documents
Further Information
Alternate Names/Synonyms:
Dipotassium bisperoxo (picolinato) oxovanadate (V)
Appearance:
Yellow crystalline solid.
CAS:
148556-27-8
EClass:
32160000
Form (Short):
liquid
Handling Advice:
Protect from light.
InChi:
InChI=1S/C6H5NO2.2O2.O.V/c8-6(9)5-3-1-2-4-7-5;2*1-2;;/h1-4H,(H,8,9);;;;/q;2*-2;;+4/p-1
InChiKey:
ABKLXJHXMGNASO-UHFFFAOYSA-M
Long Description:
Chemical. CAS: 148556-27-8. Formula: K2 [VO(O2)2C6H4NO2] . 2 H2O. MW: 331.2 . 36.0. Potent protein phosphotyrosine phosphatase inhibitor. Insulin mimetic. Angiogenesis inhibitor. PTEN inhibitor.
MDL:
MFCD28053520
Molecular Formula:
K2 [VO(O2)2C6H4NO2] . 2 H2O
Molecular Weight:
331.2 . 36.0
Package Type:
Vial
Product Description:
Potent protein phosphotyrosine phosphatase inhibitor [1]. Insulin mimetic [1]. Angiogenesis inhibitor [2]. PTEN inhibitor [3].
Purity:
>96% (51V-NMR)
SMILES:
O=C1OC[N]2=CC=CC=C12
Solubility Chemicals:
Soluble in DMSO or water. NOTE: The product is not stable in water. Decomposition starts immediately after solubilization. Rate of decomposition is slower in dry DMSO.
Transportation:
Non-hazardous
UNSPSC Category:
Biochemical Reagents
UNSPSC Number:
12352200
Use & Stability:
Stable for at least 2 years after receipt when stored at -20°C.
References
Peroxovanadium compounds. A new class of potent phosphotyrosine phosphatase inhibitors which are insulin mimetics: B.I. Posner, et al.; J. Biol. Chem. 269, 4596 (1994) | Peroxovanadium compounds as inhibitors of angiogenesis: C. J. Doillon, et al.; Angiogenesis 3, 361 (1999) | Bisperoxovanadium compounds are potent PTEN inhibitors: A.C. Schmid, et al.; FEBS Lett. 566, 35 (2004) | MicroRNA-26a-3p rescues depression-like behaviors in male rats via preventing hippocampal neuronal anomalies: Y. Li, et al.; J. Clin. Invest. ahead of print 148853 (2021)